AACC, APHL, and the CDC Announce Infectious Disease Conference
Washington DC, February 9, 2009 AACC, the Association of Public Health Laboratories, and the U.S. Centers for Disease Control & Prevention are pleased to co-sponsor a one-day conference on Tuesday, April 28, 2009. The Lab’s Changing Role in Managing Infectious Diseases will be held at the Omni Hotel, CNN Center in Atlanta, GA.
Recent advances in the field of infectious disease testing have provided the core laboratory with extraordinary opportunities to take a more prominent role in the care of patients with infectious, and sexually transmitted, diseases. In conventional testing, the laboratory’s contribution to patient care ended with identification of the organism; it was then up to physicians to prescribe treatment and monitor the patient’s progress. Now, with the availability of new platforms and test technologies, laboratories can confidently guide physician treatment of patients, help ensure that patients comply with their drug therapy regimens, provide information to help monitor treatment, and optimize the use of health care resources.
The conference faculty, which includes speakers from the CDC, will consider a range of issues including HIV/AIDS Testing in the 21st Century, managing the threat of MRSA and Clostridium difficile (C. diff), and drug resistance. Follow the link for a detailed conference program and faculty. AACC invites reporters to attend this conference and learn from top experts about the latest developments in infectious disease testing and the most successful management strategies.
This program is made possible in part by a generous educational grant from Siemens Healthcare Diagnostics.
The American Association for Clinical Chemistry (AACC) is a leading professional society dedicated to improving healthcare through laboratory medicine. Its over 9,000 members are clinical laboratory professionals, physicians, research scientists, and others involved in developing tests and directing laboratory operations.
